How to turn a downturn to your advantage
An academic, a venture capitalist and a cybersecurity executive predict which industries stand to gain as recession looms.
An academic, a venture capitalist and a cybersecurity executive predict which industries stand to gain as recession looms.
Israel’s Capsulab is developing a countertop machine designed to be like Nespresso for fresh, personalized wellness and skincare products.
Researcher Avi Schroeder’s technology for shellfish could protect us against coronavirus. He’s also working on a cancer drug from an elephant protein.
Precision medicine breakthrough from Israel helps find markers for personalized care and improving drug development for neurodegenerative diseases.
In an age of resistant bacteria, the new system could help doctors find the best antibiotic combinations, and allow for individualized treatments.
BrainQ is developing noninvasive personalized electromagnetic treatment for people with neuromuscular conditions after stroke or spinal-cord injury.
Expertise in data science has pushed Israel to the forefront in devising technologies for predicting the best course of treatment for each patient.
Israel is pioneering digital health developments for the world. Which ones will hit their stride in the coming months?
Personalized cancer treatment maker, Kite Pharma, is led by Israeli-American oncologist and based on research from Israel’s Weizmann Institute.
NovellusDx analyzes each patient’s genome sequence to deliver actionable intelligence to oncologists, helping them choose the right cancer therapy.
CURE Pharmaceutical and Israel’s Therapix Biosciences sign MoU with Israel’s Assuta Medical Centers to develop first-in-class therapeutic products.
A new center for personalized medicine in Israel gives advanced detective tools to doctors and researchers.